3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Glioma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Paraproteinemias
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms, Neuroepithelial
1
Neoplasms
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoproliferative Disorders
1
Hodgkin Disease
1
Hematologic Diseases
1
Gliosarcoma
1
Glioblastoma
1
Interventions
Temozolomide
8
sargramostim
2
pembrolizumab
2
Radiotherapy
2
Radiation
2
veliparib
1
selinexor
1
montanide ISA 51
1
lonafarnib
1
Vorinostat
1
Sucrose
1
Sonication
1
Sodium Chloride
1
Serotonin Antagonists
1
Salts
1
Photons
1
Perfusion Magnetic Resonance Imaging
1
Olanzapine
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
Loperamide
1
Lomustine
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Drug Therapy
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Carboplatin
1
CLR1404
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Gliosarcoma
×
CLR1404
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled